CA-NTT
19.5.2020 00:02:12 CEST | Business Wire | Press release
The University of California, Berkeley and NTT Corporation (NTT) today announced a connected campus pilot project that will leverage technology to transform the UC Berkeley Parking and Transportation Department by analyzing patterns, easing traffic congestion and increasing pedestrian safety in the Bancroft Way area of campus.
The pilot will incorporate NTT’s Accelerate Smart data platform and Dell Technologies’ modular data center infrastructure for edge deployments of high-definition optical sensors and IoT devices that monitor traffic-related issues. These smart technologies will provide data to facilitate enhanced traffic management and mobility. As a first step in their “Connected Campus” initiative, UC Berkeley will leverage vehicle counting and classification to make informed decisions and develop specific solutions.
“At Berkeley, we are always trying to stay on top of emerging trends in parking and transportation, and by incorporating smart technologies, our campus can serve as a test bed for new technologies that can be put into operation immediately,” said Seamus Wilmot, Director of Parking and Transportation, UC Berkeley. “Our partnership with NTT and Dell Technologies makes us more digitally-enabled and provides a better understanding for alleviating the root causes of traffic issues. These technologies will help us solve how to manage the curb space at an area that has been challenging for our students, faculty, staff and partners.”
As part of the pilot, NTT and Dell Technologies will implement smart IoT, safety and security innovations that support UC Berkeley’s Parking and Transportation Department, such as real-time alerts and traffic statistics that improve predictions and outcomes. With quantifiable data, UC Berkeley can curb congestion caused by events, ride share traffic, delivery vehicles and transit operations.
The pilot program is designed to provide automated deployment and operation of necessary information and communications technology (ICT) resources from devices and networks to the cloud. The solution will ensure UC Berkeley can focus on improving traffic conditions through analysis and process more efficiently without worrying about ICT deployment and optimization issues.
“This traffic management pilot program begins UC Berkeley’s transformation to a Connected Campus,” said Akira Shimada, Senior Executive Vice President, NTT. “Connected Campuses of the future will offer endless possibilities—for safety, crowd control, traffic and facilities management. UC Berkeley is just getting started, but as a world renowned forward-thinking academic and research University, they see the potential to improve the campus experience and operations using data and smart technologies.”
NTT, along with its operating companies, will deploy its Accelerate Smart solution, which is a secure, distributed network as a platform solution built on NTT’s innovative Cognitive Foundation™ architecture. It enables remote creation, management and operation of information and communications technology resources, from devices and networks to the cloud. It also incorporates hyperconverged infrastructure and IoT gateways from Dell Technologies, as well as virtualization software hosting predictive analytics applications from VMware.
“When we leverage longstanding relationships with great partners like NTT, our joint customers can transform the way they do business,” said Denise Millard, Senior Vice President, Global Alliances, Dell Technologies. “Together we are able to provide customers like UC Berkeley with new tools to leverage data in meaningful ways and make decisions faster to ultimately improve the experience of those on campus.”
Following the initial pilot, UC Berkeley, NTT and Dell Technologies plan to evaluate viability to extend the pilot and potentially add additional locations and use cases on campus. To learn more about the NTT accelerating smart solutions, visit NTT DATA’s website and watch the Accelerate Smart case study with the city of Las Vegas on YouTube .
About NTT
NTT believes in resolving social issues through our business operations by applying technology for good. We help clients accelerate growth and innovate for current and new business models. Our services include digital business consulting, technology and managed services for cybersecurity, applications, workplace, cloud, data center and networks all supported by our deep industry expertise and innovation.
As a top 5 global technology and business solutions provider, our diverse teams operate in 88 countries and regions and deliver services to over 190 of them. We serve 85% of Fortune Global 100 companies and thousands of other clients and communities around the world.
For more information on NTT, visit www.global.ntt/
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200518005333/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock20.4.2026 01:07:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“the Company”), a Management Service Organization operating a wide range of franchise businesses across diverse medical fields, today announced the pricing of the underwritten secondary public offering of 3,100,000 shares of the Company’s common stock by Dr. Yoshiyuki Aikawa (the “Selling Stockholder”) at the public offering price of $3.25 per share. Additionally, the Selling Stockholder has granted the underwriters a 45-day option to purchase up to an additional 465,000 shares of the Company’s common stock. The offering is expected to close on or about April 21, 2026, subject to customary closing conditions. The Company is not selling any shares of its common stock in the offering. The Selling Stockholder will receive all of the proceeds from the offering. Maxim Group LLC is acting as the sole book-running manager and Roth Capital Partners is acting as the co-manager for the offering. The offering is being made pursuant to the Com
Horse Powertrain Reveals X-Range C15 Direct Drive Powertrain for Hybridizing BEV Platforms20.4.2026 01:01:00 CEST | Press release
Horse Powertrain, a global leader in innovative and low-emission powertrain systems, will unveil a new ‘all-in-one’ powertrain at Beijing Auto Show 2026: the X-Range C15 Direct Drive. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260419640202/en/ Left-facing view of the HORSE X-Range C15 Direct Drive The ultra-compact X-Range C15 Direct Drive integrates a full hybrid powertrain – including a 4-cylinder engine, transmission, power electronics, and an electric motor – into a single compact unit with a shared housing, designed to mount to the rear subframe enabling a double isolated installation for best NVH. The X-Range C15 Direct Drive is designed as an ‘all-in-one’ powertrain to replace the rear electric drive unit of an existing BEV platform. It enables an automaker to use a single shared platform for their BEV, HEV, PHEV, and REEV lineups without any significant changes to vehicle design or production environments. The ne
Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments18.4.2026 22:12:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical treatments for serious mental illness. “We commend the Administration’s Executive Order on psychedelic treatment which recognizes the profound urgency of the mental health crisis facing millions of Americans and the potential impact FDA-approved psychedelics could have,” said Kabir Nath, CEO at Compass Pathways. “Today’s announcement aligns regulatory urgency with patient need, and we applaud the Administration for taking this important step forward in accelerating access, without compromising rigorous science. Compass is conducting the largest, most robust classic psychedelic studies to date with COMP360 synthetic psilocybin. We have recently reported two positive phase 3 trials in treatment-resistant depression (TRD) with highly statistically significant and clinically meaningful data that
2026 NAB Show Opens Tomorrow, Uniting Global Media Leaders to Shape the Future of Storytelling18.4.2026 04:08:00 CEST | Press release
CEO of Zhong, one of YouTube’s most-watched creators with 70 million subscribers and 95 million followers on all platforms, joins program The 2026 NAB Show kicks off Saturday, April 18, with the show floor and exhibits opening on April 19, highlighting the most innovative companies and bringing together the world’s most influential voices across media, entertainment and technology for the industry’s premier global event. As the only platform that convenes broadcasters, media companies, content creators and technology innovators at scale, NAB Show continues its century-long legacy as the catalyst for innovation, growth and deal-making in a rapidly evolving, multi-platform world. From artificial intelligence and the creator economy to sports, streaming and cloud transformation, NAB Show is where the tools, talent and ideas driving the future of storytelling converge. “NAB Show is where the global media ecosystem comes together not just to explore what’s next—but to build it,” said Karen
Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product17.4.2026 23:43:00 CEST | Press release
A pioneer in smoke-free tobacco products, Philip Morris International is the only company that has received modified risk tobacco product authorizations for heated tobacco products.In their order, FDA concluded that: “Scientific studies have shown that switching completely from conventional cigarettes to the IQOS system significantly reduces your body’s exposure to harmful or potentially harmful chemicals” The U.S. Food and Drug Administration (FDA) announced that it has authorized the renewal of modified risk tobacco product (MRTP) orders previously granted to PMI for two versions of the IQOS device and three variants of the tobacco consumables, commercialized under the HEETS brand. This renewal allows PMI to continue sharing reduced-exposure information with U.S. adults 21+ who use traditional tobacco products, such as combustible cigarettes. The agency concluded that renewing the IQOS and HEETS MRTP authorizations is appropriate to promote public health and is expected to benefit th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
